Neogenix Oncology, Inc.

Neogenix Oncology is a clinical stage biotechnology company focused on developing therapeutic and diagnostic products for the early detection and treatment of cancer. The company has an unusual capacity for discovery of innovative tumor specific therapeutic and diagnostic candidates due to its proprietary cancer vaccine libraries. Multicenter clinical trials are underway for pancreatic and colorectal cancer and the company has developed both serum ELISA and tissue staining tests to localize tumor specific antigens.